Literature DB >> 2067358

Adaptive regulation of alanine transport in hepatic plasma membrane vesicles from the endotoxin-treated rat.

A J Pacitti1, T R Austgen, W W Souba.   

Abstract

The mechanisms by which hepatic alanine consumption is increased during endotoxemia were investigated to gain further insight into the altered amino acid metabolism which characterizes critical illness. Rats were studied 12 hr after receiving endotoxin (ENDO) or saline. Hepatic alanine delivery was determined in vivo and hepatic alanine content was measured. Hepatocyte transport activity was studied by evaluation of [3H]-alanine accumulation in hepatocyte plasma membrane vesicles (HPMVs). Vesicle integrity was demonstrated by electron microscopy and a 14-fold enrichment in 5'-nucleotidase. Endotoxin treatment resulted in a state of hyperalaninemia and a threefold increase in hepatic alanine delivery (2.79 +/- 0.17 mu mole/100 g body weight/min in controls vs 8.13 +/- 0.98 in ENDO animals; P less than 0.001). Data from HPMVs revealed the presence of a high- and low-affinity component of alanine transport. Endotoxin treatment resulted in a 30% decrease in the Vmax of the high-affinity transport component (3355 +/- 177 pmole/mg protein/10 sec in controls vs 2338 +/- 270 in the ENDO group; P less than 0.05). Concomitant with the observed changes in alanine delivery and transport activity, endotoxin treatment resulted in a 56% rise in hepatic alanine content (2.53 +/- 0.29 mu mole/g liver in controls vs 3.95 +/- 0.23 in ENDO; P less than 0.005). These data indicate that the accelerated hepatic alanine consumption which occurs during endotoxemia is primarily the result of increased hepatic substrate delivery. Despite the resultant repression of transport activity, delivery begins to outdistance the metabolic capacity of the hepatocyte to utilize alanine and intracellular alanine levels rise.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2067358     DOI: 10.1016/0022-4804(91)90068-w

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

1.  Inhibition of glycerol metabolism in hepatocytes isolated from endotoxic rats.

Authors:  P Leclercq; C Filippi; B Sibille; S Hamant; C Keriel; X M Leverve
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

2.  Arginine transport in human liver. Characterization and effects of nitric oxide synthase inhibitors.

Authors:  Y Inoue; B P Bode; D J Beck; A P Li; K I Bland; W W Souba
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

3.  Tumor necrosis factor stimulates amino acid transport in plasma membrane vesicles from rat liver.

Authors:  A J Pacitti; Y Inoue; W W Souba
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

4.  Growth hormone regulates amino acid transport in human and rat liver.

Authors:  A J Pacitti; Y Inoue; D A Plumley; E M Copeland; W W Souba
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

5.  Administration of Escherichia coli endotoxin to rat increases liver mass and hepatocyte volume in vivo.

Authors:  D Qian; J T Brosnan
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

6.  Normalization of tumor-induced increases in hepatic amino acid transport after surgical resection.

Authors:  N J Espat; B P Bode; D S Lind; E M Copeland; W W Souba
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

7.  Accelerated hepatic arginine transport in the tumor-bearing rat.

Authors:  N J Espat; E M Copeland; W W Souba
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.